Mei Pharma, Inc.
MEIP
Revenue
0.00
0.000.00%
3 Months ChangeAssets
41.38M
▼-29.89M▼-41.94%
3 Months ChangeLiabilities
8.36M
▼-11.88M▼-58.70%
3 Months ChangeFree Cash Flow
-18.49M
▼-3.65M▼-24.56%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-25
Form 8-K
ID: 0000950170-24-117406
2024-09-19
Form 8-K
ID: 0000950170-24-108171
2024-08-02
Form 8-K
ID: 0000950170-24-089939
2024-07-30
Form 8-K
ID: 0000950170-24-087841
2024-07-22
Form 8-K
ID: 0000950170-24-085347
2024-06-25
Form 8-K
ID: 0000929638-24-002259
2024-05-21
Form 8-K
ID: 0000950170-24-062739
2024-05-09
Form 8-K
ID: 0000950170-24-056850
2024-05-09
Form 10-Q
ID: 0000950170-24-056834
2024-02-21
Form 8-K
ID: 0000950170-24-017875